These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antipsychotic prescribing patterns in the Texas prison system. Baillargeon J; Contreras SA J Am Acad Psychiatry Law; 2001; 29(1):48-53. PubMed ID: 11302386 [TBL] [Abstract][Full Text] [Related]
5. How long should treatments be continued? Craig JC; Webster AC; Loy C BMJ; 2010 Aug; 341():c4102. PubMed ID: 20724403 [No Abstract] [Full Text] [Related]
6. Commentary: Antipsychotic prescribing practices in the Texas prison system. Trestman RL J Am Acad Psychiatry Law; 2001; 29(1):54-7. PubMed ID: 11302387 [No Abstract] [Full Text] [Related]
7. [Use of neuroleptics in psychotic states]. Gayral LF; Escande M Rev Prat; 1984 Mar; 34(13):607-17. PubMed ID: 6143387 [No Abstract] [Full Text] [Related]
9. [Antipsychotic agents and weight gain]. Raaska K Duodecim; 2002; 118(2):157-62. PubMed ID: 12229110 [No Abstract] [Full Text] [Related]
10. Are there any news about the antipsychotic medications in the elderly? Cucinotta D; Minardi M; Lanfranchi G; Reggiani A; Savorani G Arch Gerontol Geriatr; 2007; 44 Suppl 1():133-7. PubMed ID: 17317446 [TBL] [Abstract][Full Text] [Related]
11. The CATIE study and its implications for antipsychotic drug use. Janicak PG Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293 [No Abstract] [Full Text] [Related]
12. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse. Moncrieff J Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655 [TBL] [Abstract][Full Text] [Related]
13. An overview of the treatment of schizoaffective disorder. McElroy SL; Keck PE; Strakowski SM J Clin Psychiatry; 1999; 60 Suppl 5():16-21; discussion 22. PubMed ID: 10192403 [TBL] [Abstract][Full Text] [Related]
14. Reply to article by Margolese and associates on tolerance and rebound during maintenance with quetiapine. Goldstein J; Macfadden W J Clin Psychopharmacol; 2004 Feb; 24(1):102-3; author reply 103-4. PubMed ID: 14709961 [No Abstract] [Full Text] [Related]
15. The role of the psychiatrist in improving patient compliance. Hotujac L Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():27-33. PubMed ID: 17262009 [TBL] [Abstract][Full Text] [Related]
16. [Brighter prospects for patients with psychoses? New neuroleptics may improve the long-term prognosis]. Lindström L Lakartidningen; 1996 Nov; 93(45):3989-90. PubMed ID: 8984249 [No Abstract] [Full Text] [Related]
17. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
18. Antipsychotic use in older adults with Parkinson's disease. Marras C; Kopp A; Qiu F; Lang AE; Sykora K; Shulman KI; Rochon PA Mov Disord; 2007 Feb; 22(3):319-23. PubMed ID: 17149718 [TBL] [Abstract][Full Text] [Related]
19. A brief history of depot neuroleptics. Simpson GM J Clin Psychiatry; 1984 May; 45(5 Pt 2):3-4. PubMed ID: 6143745 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome in patients with psychotic disorders in the Netherlands. Schorr SG; Slooff CJ; Bruggeman R; Taxis K J Clin Psychopharmacol; 2009 Aug; 29(4):399-402. PubMed ID: 19593188 [No Abstract] [Full Text] [Related] [Next] [New Search]